
Rgenta Therapeutics recipient of the Servier’s 2020 LabCentral Golden Ticket
05/05/2020
Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline